Evidence map›Paper›PMID 20386492›Full record

ArticlePediatric research2010

Angiotensin II regulates NOS expression in afferent arterioles of the developing porcine kidney.

Brian B Ratliff, Miroslav Sekulic, Justin Rodebaugh, Michael J Solhaug

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Identification and characterization of a functional mitochondrial angiotensin system.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Brian B RatliffDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23501, USA. ratlifbb@gmail.com
Miroslav Sekulic
Justin Rodebaugh
Michael J Solhaug
Eastern Virginia Medical School · US

Funding

REGULATION OF DEVELOPMENTAL RENAL HEMODYNAMICSR01HL052765 · NHLBI · EASTERN VIRGINIA MEDICAL SCHOOL · PI SOLHAUG, MICHAEL JOHN · 1997 to 2005
$1.1M
NHLBI NIH HHS 2R01HL52765-04A2NHLBI NIH HHS R01 HL052765
6 · The paper itself

Abstract

NO protection is crucial against angiotensin II (ANG II) mediated vasoconstriction in postnatal preglomerular resistance vessels. Although whole kidney NOS is developmentally regulated, NOS regulation in developing renal resistance vessels is unknown. The hypothesis was NOS expression and function in developing afferent arterioles are regulated by ANG II through AT1 and AT2 receptors. Afferent arterioles from porcine kidneys, ages newborn, 7, 21 d, and adult, were dissected using a polybead perfusion technique. Dissected afferent arterioles were treated with ANG II and with either the AT1 receptor inhibitor candesartan or the AT2 receptor inhibitor PD 123319 and evaluated for NOS isoform expression and NOS enzymatic activity. Although NOS activity and neuronal NOS (nNOS) expression were greater in the newborn than in the adult, endothelial NOS (eNOS) expression was greater in the adult. ANG II increased NOS activity and eNOS expression at all ages, but nNOS expression only in developing afferents. AT1 and AT2 receptor blockade significantly attenuated NOS activity and eNOS expression at all ages, but nNOS expression only in developing afferents. ANG II regulates nNOS and eNOS expression and NOS activity in afferent arterioles of the developing kidney via AT1 and AT2 receptors.

Indexed as

KidneyAdultAngiotensin IIAngiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersAnimalsArteriolesHemodynamicsHumansInfant, NewbornIsoenzymesNitric OxideNitric Oxide Synthase Type INitric Oxide Synthase Type IIIReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2Angiotensin IIAngiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersIsoenzymesNitric OxideNitric Oxide Synthase Type INitric Oxide Synthase Type IIIReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2

Identifiers

PMID20386492
PMCPMC2891964
OpenAlexW1975761750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.